Quantum Healthcare Limited (SGX:V8Y)

Quantum Healthcare Statistics

Total Valuation

SGXC:V8Y has a market cap or net worth of SGD 12.59 million. The enterprise value is 15.22 million.

Market Cap	12.59M
Enterprise Value	15.22M

Important Dates

The next estimated earnings date is Friday, August 14, 2026.

Earnings Date	Aug 14, 2026
Ex-Dividend Date	n/a

Share Statistics

SGXC:V8Y has 12.59 billion shares outstanding. The number of shares has increased by 17.77% in one year.

Current Share Class	12.59B
Shares Outstanding	12.59B
Shares Change (YoY)	+17.77%
Shares Change (QoQ)	+55.84%
Owned by Insiders (%)	58.49%
Owned by Institutions (%)	0.38%
Float	2.50B

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	0.95
PB Ratio	-10.88
P/TBV Ratio	n/a
P/FCF Ratio	7.83
P/OCF Ratio	7.56
PEG Ratio	n/a

Enterprise Valuation

The stock's EV/EBITDA ratio is 9.96, with an EV/FCF ratio of 9.47.

EV / Earnings	-5.41
EV / Sales	1.15
EV / EBITDA	9.96
EV / EBIT	n/a
EV / FCF	9.47

Financial Position

The company has a current ratio of 0.51

Current Ratio	0.51
Quick Ratio	0.50
Debt / Equity	n/a
Debt / EBITDA	2.88
Debt / FCF	2.74
Interest Coverage	-0.95

Financial Efficiency

Return on Equity (ROE)	n/a
Return on Assets (ROA)	-1.71%
Return on Invested Capital (ROIC)	-59.98%
Return on Capital Employed (ROCE)	-24.21%
Weighted Average Cost of Capital (WACC)	7.31%
Revenue Per Employee	143,326
Profits Per Employee	-30,598
Employee Count	92
Asset Turnover	1.15
Inventory Turnover	128.05

Taxes

In the past 12 months, SGXC:V8Y has paid 65,000 in taxes.

Income Tax	65,000
Effective Tax Rate	n/a

Stock Price Statistics

Beta (5Y)	0.65
52-Week Price Change	n/a
50-Day Moving Average	0.00
200-Day Moving Average	0.00
Relative Strength Index (RSI)	47.47
Average Volume (20 Days)	3,482,355

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, SGXC:V8Y had revenue of SGD 13.19 million and -2.82 million in losses. Loss per share was -0.00.

Revenue	13.19M
Gross Profit	5.95M
Operating Income	-314,000
Pretax Income	-2.83M
Net Income	-2.82M
EBITDA	274,000
EBIT	-314,000
Loss Per Share	-0.00

Balance Sheet

The company has 2.30 million in cash and 4.41 million in debt, with a net cash position of -2.11 million or -0.00 per share.

Cash & Cash Equivalents	2.30M
Total Debt	4.41M
Net Cash	-2.11M
Net Cash Per Share	-0.00
Equity (Book Value)	-1.16M
Book Value Per Share	-0.00
Working Capital	-4.72M

Cash Flow

In the last 12 months, operating cash flow was 1.66 million and capital expenditures -57,000, giving a free cash flow of 1.61 million.

Operating Cash Flow	1.66M
Capital Expenditures	-57,000
Depreciation & Amortization	588,000
Net Borrowing	-2.38M
Free Cash Flow	1.61M
FCF Per Share	0.00

Margins

Gross margin is 45.13%, with operating and profit margins of -2.38% and -21.35%.

Gross Margin	45.13%
Operating Margin	-2.38%
Pretax Margin	-21.48%
Profit Margin	-21.35%
EBITDA Margin	2.08%
EBIT Margin	-2.38%
FCF Margin	12.19%

Dividends & Yields

SGXC:V8Y does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-17.77%
Shareholder Yield	-17.77%
Earnings Yield	-22.36%
FCF Yield	12.77%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	4